SLC6A9 helps control levels of glycine, a chemical messenger that supports signaling in the brain, spinal cord, and breathing centers. The protein made by this gene helps your cells clear extra glycine after nerve cells communicate, which keeps signals balanced. If the SLC6A9 gene does not work properly, glycine can build up and some babies may have low muscle tone, feeding or breathing problems, an exaggerated startle, and later movement or learning difficulties. This rare inherited condition is called GLYT1 deficiency.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some provide the directions for producing proteins, which do much of the cell’s work. Others mainly help control when certain processes happen, where they happen, and how active they are. Together, genes affect how your body develops and functions, and they can also influence how you respond to food, stress, and medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
SLC6A9Gene function
What if the gene works
The SLC6A9 gene helps move glycine, a signaling amino acid, back into cells. This helps keep brain and spinal cord signaling balanced.
Risk
What if the gene does not work
More severe variants in the SLC6A9 gene can cause glycine transporter 1 encephalopathy, often starting in newborns with breathing problems, low muscle tone, and strong startle responses. Milder variants may cause a less severe course.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the SLC6A9 gene is currently established in clinical guidelines for pathogenic variants. The SLC6A9 gene is also being studied as a drug target, with glycine transporter 1 inhibitors explored in neuropsychiatric research, but this has not led to gene directed care.
Conditions associated with SLC6A9
Gene function
What if the gene works
If you carry the SLC6A9 gene, your cells use it to move glycine, a small amino acid that also works as a nerve messenger. This is central to how the SLC6A9 gene controls glycine levels in the brain and spinal cord. Understanding what the SLC6A9 gene does helps explain how nerve cells fine tune everyday communication.
The SLC6A9 gene makes a transporter that pulls glycine from outside the cell to the inside. It uses sodium and chloride, two charged particles, to move glycine across the cell membrane.
In the brain and spinal cord, this transporter helps control how much glycine stays around nerve cells. That steady level helps nerve messages stay clear instead of lingering longer than needed.
Glycine also helps activate NMDA receptors, proteins that help nerve cells respond to signals linked to learning and memory. By setting glycine levels near synapses (the contact points between nerve cells), the SLC6A9 gene supports more precise cell to cell communication.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC6A9 gene can reduce glycine transport by changing the protein's shape, stability, or placement in the cell membrane. This is how SLC6A9 gene variants affect protein function: milder changes may only partly lower transport, while more disruptive variants can sharply reduce it or stop it almost completely. Some variants also weaken the transporter's interactions with nearby cell membrane proteins, which can further change glycine uptake.
How variants are linked to conditions
Rare pathogenic variants in both copies of the SLC6A9 gene are linked to GLYT1 deficiency, a very uncommon inherited condition. In reported babies, SLC6A9 gene variants have been associated with low muscle tone, breathing and feeding problems, developmental delay, and changes seen on brain scans. When two pathogenic variants are found, this can confirm the diagnosis. Common variants in the SLC6A9 gene have not shown a consistent link to common health conditions.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely seen across the population. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well understood variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC6A9 gene. If you have a change in SLC6A9 or a family history of related concerns, a doctor or genetic counselor can help put your personal risk in context.
Inheritance of SLC6A9 variants
The SLC6A9 gene inheritance pattern linked to known SLC6A9 related disease is autosomal recessive. This means a person usually inherits one altered copy of the SLC6A9 gene from each parent. Parents who each carry one variant are often unaffected, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. This pattern applies equally to sons and daughters.
What does my SLC6A9 result mean for my family?
For families with a disease-causing SLC6A9 result linked to the known related condition, it is usually passed down in a recessive pattern. This means brothers and sisters could also be affected, and parents are often healthy carriers; other relatives may be carriers too. Family members may want to discuss whether the result is relevant to them, especially when planning a pregnancy.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, genetic testing for SLC6A9 variants uses a blood or saliva sample to read the SLC6A9 gene in your DNA. Results can show whether a specific change is present, absent, or uncertain, depending on the type of test used.
When should I consider getting a genetic test?
Genetic testing for the SLC6A9 gene may be considered when a baby or child has unexplained severe low muscle tone, breathing problems, unusual startle episodes, seizures, or developmental delay. It may also be considered if similar problems have affected close relatives or if doctors are trying to confirm the cause of a serious newborn illness.
A genetic result is only one part of your health story
Genetic results can be informative, though how much they reveal depends on the condition and on the kind of variant present. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. With some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and is most useful when considered with the rest of a person’s care. In other situations, a genetic finding can give a clear answer. For topics like medication response, these results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in the genes involved in drug handling can change how quickly a medicine is absorbed, broken down, or cleared, so the same treatment may work better for one person than another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect responses to medications. It examines relationships between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can help support treatment decisions that are more informed and more personalized. If you want to read more about this topic, you can learn more in the LearnHub.
Drugs influenced by the SLC6A9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have side effects, poor symptom control, or questions about how a medicine may affect you, talk with your doctor or pharmacist.
History
SLC6A9 entered the scientific literature in the 1990s, during a period when researchers were identifying many genes involved in nerve signaling. From these first observations, research expanded steadily. Scientists mapped the gene, compared it with related transporter genes, and clarified that it belongs to a larger family important in brain communication. Interest later grew in both psychiatry research and rare inherited startle conditions, which brought SLC6A9 into more focused medical genetics work. Over time, descriptions became more precise as genetic studies linked specific SLC6A9 variants with human disease and helped place the gene within modern neurogenetics.